333 related articles for article (PubMed ID: 18473726)
1. DNA repair proteins as molecular targets for cancer therapeutics.
Kelley MR; Fishel ML
Anticancer Agents Med Chem; 2008 May; 8(4):417-25. PubMed ID: 18473726
[TBL] [Abstract][Full Text] [Related]
2. DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer.
Velic D; Couturier AM; Ferreira MT; Rodrigue A; Poirier GG; Fleury F; Masson JY
Biomolecules; 2015 Nov; 5(4):3204-59. PubMed ID: 26610585
[TBL] [Abstract][Full Text] [Related]
3. Helicases as prospective targets for anti-cancer therapy.
Gupta R; Brosh RM
Anticancer Agents Med Chem; 2008 May; 8(4):390-401. PubMed ID: 18473724
[TBL] [Abstract][Full Text] [Related]
4. Targeting base excision repair for chemosensitization.
Adhikari S; Choudhury S; Mitra PS; Dubash JJ; Sajankila SP; Roy R
Anticancer Agents Med Chem; 2008 May; 8(4):351-7. PubMed ID: 18473720
[TBL] [Abstract][Full Text] [Related]
5. Targeting BER enzymes in cancer therapy.
Visnes T; Grube M; Hanna BMF; Benitez-Buelga C; Cázares-Körner A; Helleday T
DNA Repair (Amst); 2018 Nov; 71():118-126. PubMed ID: 30228084
[TBL] [Abstract][Full Text] [Related]
6. Targeting DNA repair proteins for cancer treatment.
Tell G; Wilson DM
Cell Mol Life Sci; 2010 Nov; 67(21):3569-72. PubMed ID: 20706767
[No Abstract] [Full Text] [Related]
7. Targeting poly (ADP) ribose polymerase I (PARP-1) and PARP-1 interacting proteins for cancer treatment.
Sakamoto-Hojo ET; Balajee AS
Anticancer Agents Med Chem; 2008 May; 8(4):402-16. PubMed ID: 18473725
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers to assess the targeting of DNA repair pathways to augment tumor response to therapy.
Nowsheen S; Whitley AC; Yang ES
Curr Mol Med; 2012 Jul; 12(6):788-803. PubMed ID: 22292444
[TBL] [Abstract][Full Text] [Related]
9. Repair and translesion DNA polymerases as anticancer drug targets.
Maga G; Hübscher U
Anticancer Agents Med Chem; 2008 May; 8(4):431-47. PubMed ID: 18473728
[TBL] [Abstract][Full Text] [Related]
10. DNA repair helicases as targets for anti-cancer therapy.
Gupta R; Brosh RM
Curr Med Chem; 2007; 14(5):503-17. PubMed ID: 17346143
[TBL] [Abstract][Full Text] [Related]
11. DNA end-processing enzyme polynucleotide kinase as a potential target in the treatment of cancer.
Allinson SL
Future Oncol; 2010 Jun; 6(6):1031-42. PubMed ID: 20528239
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology in cancer therapy: targeting the inhibition of key DNA repair pathways.
Aziz K; Nowsheen S; Georgakilas AG
Curr Mol Med; 2010 Oct; 10(7):626-39. PubMed ID: 20712589
[TBL] [Abstract][Full Text] [Related]
13. Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target.
Plummer R
Clin Cancer Res; 2010 Sep; 16(18):4527-31. PubMed ID: 20823148
[TBL] [Abstract][Full Text] [Related]
14. DNA repair inhibitors in cancer treatment.
Sánchez-Pérez I
Clin Transl Oncol; 2006 Sep; 8(9):642-6. PubMed ID: 17005466
[TBL] [Abstract][Full Text] [Related]
15. DNA damage repair and response proteins as targets for cancer therapy.
Lieberman HB
Curr Med Chem; 2008; 15(4):360-7. PubMed ID: 18288990
[TBL] [Abstract][Full Text] [Related]
16. Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches.
Dietlein F; Thelen L; Reinhardt HC
Trends Genet; 2014 Aug; 30(8):326-39. PubMed ID: 25017190
[TBL] [Abstract][Full Text] [Related]
17. Non-homologous DNA end joining in anticancer therapy.
Pastwa E; Malinowski M
Curr Cancer Drug Targets; 2007 May; 7(3):243-50. PubMed ID: 17504121
[TBL] [Abstract][Full Text] [Related]
18. Targeting SMARCAL1 as a novel strategy for cancer therapy.
Zhang L; Fan S; Liu H; Huang C
Biochem Biophys Res Commun; 2012 Oct; 427(2):232-5. PubMed ID: 22995303
[TBL] [Abstract][Full Text] [Related]
19. The DNA damage response: implications for tumor responses to radiation and chemotherapy.
Goldstein M; Kastan MB
Annu Rev Med; 2015; 66():129-43. PubMed ID: 25423595
[TBL] [Abstract][Full Text] [Related]
20. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
